OpenAI buys Orchestra Bio to streamline drug development with AIOpenAI has acquired startup Orchestra Bio, merging its AI agents into Rosalind to help drug companies manage complex development timelines.https://newisty.com/blog/openai-buys-orchestra-bio-to-streamline-drug-development-with-ai?utm_source=social&utm_campaign=crypto_news#openai #orchestrabio #ai
OpenAI buys Orchestra Bio to streamline drug development with AIOpenAI has acquired startup Orchestra Bio, merging its A...